Company profile for Sanegene Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SanegeneBio is an RNA therapeutic start-up company dedicated to developing novel RNAi-based medicines to improve life and address unmet medical needs worldwide. Founded in 2020, propelled by a team of industry-leading experts, our cutting-edge delivery technologies and discovery platform enables tissue-specific delivery of a wide range of RNA therapeutics to efficiently knock down disease-causing genes. Our fast-growing RNAi p...
SanegeneBio is an RNA therapeutic start-up company dedicated to developing novel RNAi-based medicines to improve life and address unmet medical needs worldwide. Founded in 2020, propelled by a team of industry-leading experts, our cutting-edge delivery technologies and discovery platform enables tissue-specific delivery of a wide range of RNA therapeutics to efficiently knock down disease-causing genes. Our fast-growing RNAi portfolio covers a broad range of therapeutic areas including cardio-metabolic diseases, infectious diseases, central nervous system and ocular diseases, immune disorders, and cancer.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
300 TradeCenter, Suite 5500, Woburn, MA 01801
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/innovent-and-sanegenebio-announce-phase-1-clinical-data-for-ibi3016-presented-at-american-heart-association-aha-2025-annual-meeting-302609412.html

PR NEWSWIRE
09 Nov 2025

https://www.prnewswire.com/news-releases/sanegenebio-announces-rnai-licensing-and-research-collaboration-with-lilly-302609299.html

PR NEWSWIRE
08 Nov 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty